MACHINE-READABLE RIGHTS

Licensed

AI TRAINING
allowed
RIGHTS BASIS
Controlled EMJ.LIFE publication or participation record authorized for SNN public distribution and machine use.
LICENSE
EMJ.LIFE publication authorization for SNN

This record preserves EMJ.LIFE’s June 2026 position paper on risk prioritisation, monitoring and evidence continuity. The Commission-hosted twenty-page supporting attachment names EMJ LIFE Holdings Pte. Ltd. and Anderson Yu and bears an Ares registration stamp dated 17 June 2026. The original seven-page SNN controlled register remains available below. A separate follow-up compares the paper with the November factual summary of stakeholder contributions. The comparison is SNN editorial analysis; named citation, adoption, endorsement and individual policy influence are not established.

OFFICIAL-SOURCE FOLLOW-UP · 2026-11-13

Official attachment and subsequent consultation summary

The official supporting attachment is now publicly verifiable. Its Ares registration date is separate from the exact portal transmission time. The November summary provides a subsequent record of stakeholder themes, with no individual attribution of influence.

Risk Prioritisation, Monitoring and Evidence Continuity in Due Diligence Systems ↗
20 PDF pages · Ares(2026)6179158 · registration 2026-06-17
Public Consultation on the CSDDD Guidelines: Factual summary report ↗
5 PDF pages · Ares(2026)10552819 · registration 2026-11-11

Page-specific thematic comparison

Prepared by Sustainability News Network. PDF page numbers, counted from the cover, not printed internal page labels. These are editorial comparisons of two documents.

ThemeJune PCP01November factual summaryBounded assessment
Interoperability and reduced duplication

PCP01 describes interoperability across systems and initiatives as a way to reduce repeated work and improve consistency.

PDF pp. 13–14, 15–16

The summary records interoperability and avoidance of duplication among digital-tool concerns, and fragmentation and interoperability among initiative challenges.

PDF pp. 2, 4 · Q10–Q14; Q36–Q38
Direct thematic correspondence; no individual attribution.
Data quality and reliability

PCP01 identifies information quality and reliability as collaboration challenges and seeks more consistent information across initiatives.

PDF pp. 15–16

The summary records data quality as a concern in the use of digital tools.

PDF pp. 2 · Q10–Q14
Thematic correspondence; no proof of a shared implementation or validated product capability.
Human judgement and control

PCP01 treats professional judgement and decisions on prioritisation, stakeholder engagement and remediation as human responsibilities.

PDF pp. 13

The summary records human control over digital solutions and the need to preserve affected people’s voice and stakeholder engagement.

PDF pp. 2 · Q10–Q14
Related governance principles; human control and professional judgement are not asserted to be identical formulations.
Dynamic risk prioritisation

PCP01 proposes periodic reassessment of priorities as circumstances and information change.

PDF pp. 6, 10–11

The summary records stakeholder involvement and regular review in prioritisation.

PDF pp. 2 · Q15–Q16
Direct thematic correspondence on review over time; the full evidence-continuity framework is not shown to have been adopted.
Collaboration with retained company responsibility

PCP01 describes initiatives as enabling mechanisms that do not replace an organisation’s own due-diligence responsibilities.

PDF pp. 15–16

The summary records collaborative functions while stressing in-scope companies’ own responsibilities.

PDF pp. 4 · Q36–Q38
Direct thematic correspondence; no institutional endorsement or attribution of policy influence.

Evidence and attribution boundaries

  • The official PDF verifies public availability of the named supporting paper. The full portal respondent inventory and response identifier were not independently retrieved in this update.
  • 17 June 2026 is the original paper’s Ares registration date. The original June 2026 month-precision submission account is retained; an exact transmission or private receipt time is not inferred.
  • The five-page factual summary aggregates 508 responses and is not the Commission’s official position. Its open-text findings do not quantify support.
  • No named citation to EMJ.LIFE or Anderson Yu was located in the summary. Correspondence does not establish causation, substantive acceptance, adoption, endorsement or product validation.
  • Evidence continuity is a broader PCP01 argument. The summary does not establish adoption of the complete framework or later PDEI terminology.
  • The seven-page SNN controlled register, twenty-page official supporting attachment and five-page aggregate summary retain distinct roles and rights. No controlled PDF is replaced and no participation act is added.
Read the source observations and comparison data ↗
COMPLETE CONTROLLED FILE

Read the complete controlled PDF

Preparing controlled document...

TRACEABLE CONTROLLED RESEARCH RECORD

Official source and document control

Open controlled readable file ↗
← Consultation CenterSource registry ↗